This inventor holds 2 USPTO granted patents and 7 published patent applications. Top assignee: University of Rochester. Active years: 2018-2019.
Company Filing History:
Years Active: 2018-2019
Title: Maureen Newman: Innovator in Bone Therapeutics
Introduction
Maureen Newman is a distinguished inventor based in Rochester, NY (US). She has made significant contributions to the field of bone therapeutics, holding 2 patents that focus on innovative methods for promoting bone formation. Her work is particularly relevant for individuals suffering from conditions such as osteoporosis, bone cancer, and bone fractures.
Latest Patents
One of her latest patents is titled "Compositions and methods for controlled localized delivery of bone forming therapeutic agents." This invention provides compositions and methods for controllable local delivery of a therapeutic agent to promote bone formation. In certain embodiments, the invention is used as a treatment for subjects with osteoporosis, bone cancer, or bone fractures. The invention features a therapeutic agent tethered to a polymer, forming a therapeutic-tethered macromer, where the therapeutic agent is controllably released from the conjugate by degradation of the tether. In specific embodiments, the therapeutic agent is an inhibitor of GSK3β, and the composition is targeted to a site in need of bone formation.
Career Highlights
Maureen Newman is affiliated with the University of Rochester, where she continues her research and development in the field of bone therapeutics. Her innovative approaches have garnered attention and recognition within the scientific community.
Collaborations
Some of her notable coworkers include Danielle Benoit and J Edward Puzas, who contribute to her research endeavors and collaborative projects.
Conclusion
Maureen Newman is a pioneering inventor whose work in bone therapeutics is making a significant impact on medical treatments for bone-related conditions. Her innovative patents and collaborations highlight her commitment to advancing healthcare solutions.
